Developing a Whole-body MRI and Diffusion-weighted Imaging State-of-the-art Protocol: a Pilot Study

Launched by FONDAZIONE POLICLINICO UNIVERSITARIO AGOSTINO GEMELLI IRCCS · Jul 30, 2024

Keywords

ClinConnect Summary

This clinical trial is looking at a new way to perform whole-body magnetic resonance imaging (WB-MRI) to help manage cancer patients more effectively. WB-MRI is a type of scan that uses magnets and radio waves to create detailed images of the entire body without using harmful radiation. The study aims to develop a faster method for this imaging, especially focusing on a technique called diffusion-weighted MRI (DWI) that can help doctors see how well cancer treatments are working. By reducing the time it takes to get these images, the researchers hope to make the process easier and more comfortable for patients.

To participate in this trial, you need to be at least 18 years old and have a diagnosis of certain types of cancers, such as multiple myeloma, lymphoma, or breast cancer. Additionally, individuals with specific genetic conditions that increase cancer risk may also be eligible. If you join the study, you will undergo the new imaging technique, and your experience and results will help researchers improve this important tool for cancer care. Please note that the trial is not yet recruiting participants, so more information will be available as the study progresses.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Age ≥18 years old;
• • Patients with diagnosis of multiple myeloma, lymphoma, lung, prostate, breast, colorectal and gynecologic cancers;
• • Patients with genetic syndromes responsible for an increased predisposition to neoplasms (e.g. Li Fraumeni syndrome);
• • Signed written informed consent to personal data treatment for research purposes
• Exclusion Criteria:
• • Age \<18 years old;
• • Refusal to sign the written informed consent to personal data treatment for research purposes.